Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;298(3):L335-47.
doi: 10.1152/ajplung.00190.2009. Epub 2009 Dec 18.

Functional importance of the NH2-terminal insertion sequence of lung surfactant protein B

Affiliations

Functional importance of the NH2-terminal insertion sequence of lung surfactant protein B

Shelli L Frey et al. Am J Physiol Lung Cell Mol Physiol. 2010 Mar.

Abstract

Lung surfactant protein B (SP-B) is required for proper surface activity of pulmonary surfactant. In model lung surfactant lipid systems composed of saturated and unsaturated lipids, the unsaturated lipids are removed from the film at high compression. It is thought that SP-B helps anchor these lipids closely to the monolayer in three-dimensional cylindrical structures termed "nanosilos" seen by atomic force microscopy imaging of deposited monolayers at high surface pressures. Here we explore the role of the SP-B NH(2) terminus in the formation and stability of these cylindrical structures, specifically the distribution of lipid stack height, width, and density with four SP-B truncation peptides: SP-B 1-25, SP-B 9-25, SP-B 11-25, and SP-B 1-25Nflex (prolines 2 and 4 substituted with alanine). The first nine amino acids, termed the insertion sequence and the interface seeking tryptophan residue 9, are shown to stabilize the formation of nanosilos while an increase in the insertion sequence flexibility (SP-B 1-25Nflex) may improve peptide functionality. This provides a functional understanding of the insertion sequence beyond anchoring the protein to the two-dimensional membrane lining the lung, as it also stabilizes formation of nanosilos, creating reversible repositories for fluid lipids at high compression. In lavaged, surfactant-deficient rats, instillation of a mixture of SP-B 1-25 (as a monomer or dimer) and synthetic lung lavage lipids quickly improved oxygenation and dynamic compliance, whereas SP-B 11-25 surfactants showed oxygenation and dynamic compliance values similar to that of lipids alone, demonstrating a positive correlation between formation of stable, but reversible, nanosilos and in vivo efficacy.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Surface pressure vs. molecular area isotherms for lung surfactant model mixtures of 7:3 dipalmitoylphosphatidylcholine:palmitoyloleoylphosphatidylglycerol (DPPC:POPG) and various lung surfactant protein B (SP-B) truncation peptides 10 wt%. Thick black line, no peptide; dashed black line, SP-B 1–25; hatched line, SP-B 9–25; dashed dotted line, SP-B 11–25; thin black line, SP-B 1–25Nflex. Inset: plateau region of monolayers with SP-B 9–25 and SP-B 11–25. All isotherms were taken on pure water at 25°C.
Fig. 2.
Fig. 2.
Fluorescence microscope images of 7:3 DPPC:POPG with 10 wt% SP-B 1–25 (A) at a surface pressure of 55 mN/m. Note the speckles of increased intensity (nanosilos) in the bright phase. B: on decompression, fluorescent speckles gradually disappear, indicating reversible respreading of the collapsed material stored in the nanosilos into the lipid monolayer.
Fig. 3.
Fig. 3.
Atomic force microscopy (AFM) topographic images of 7:3 DPPC:POPG monolayers containing 10 wt% SP-B truncation peptides transferred at 55 mN/m from a water subphase at 25°C (z-scale 5 nm). A, no peptide; B, SP-B 1–25; C, SP-B 9–25; D, SP-B 11–25; E, SP-B 1–25Nflex.
Fig. 4.
Fig. 4.
AFM topographic images of 7:3 DPPC:POPG monolayers with 10 wt% (A1 and A2) SP-B 1–25 and (B) SP-B 1–25Nflex monolayers transferred at 55 mN/m from a 40 wt% glycerol subphase at 25°C (z-scale 5 nm). All nanosilos are ∼5 nm above the height of the monolayer.
Fig. 5.
Fig. 5.
Oxygenation, expressed as arterial Po2 (mmHg), in rats treated with porcine SP-B surfactant (positive control), lipids (negative control), and the four experimental surfactant preparations with monomeric or dimeric SP-B 1–25 and SP-B 11–25 peptides. The differences between porcine SP-B surfactant and monomeric and dimeric SP-B 1–25 surfactant and the differences between SP-B 1–25 and SP-B 11–25 surfactants or lipids alone are significant (P < 0.001).
Fig. 6.
Fig. 6.
Dynamic compliance (ml · kg−1 · cmH2O−1) in rats treated with porcine SP-B surfactant (positive control), lipids (negative control), and the four experimental surfactant preparations with monomeric or dimeric SP-B 1–25 and SP-B 11–25 peptides. The differences between porcine SP-B surfactant, monomeric and dimeric SP-B 1–25 surfactant, and monomeric and dimeric SP-B 11–25 surfactants or lipids alone are significant (P < 0.005).
Fig. 7.
Fig. 7.
Cross-sectional view of bicelle structures. A, unstable structure where the edge is exposed to water; B, edge stabilized by more fluid, shorter tailed lipids; C, edge stabilized by amphiphilic peptide.
Fig. 8.
Fig. 8.
Proposed bicelle structures for SP-B 1–25 and 1–25Nflex (A); SP-B 9–25 (B). Note the NH2-terminal insertion sequence is anchored between the 2 layers of the bilayer. C: comparison of stable bicelle nanosilo to fluid lipid vesicle.

Similar articles

Cited by

References

    1. Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Weidemann HP, Raventos AA, Lemaire F, Long W, Zaccardelli DS, Pattishall EN. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 334: 1417–1421, 1996 - PubMed
    1. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 97: 517–523, 1959 - PubMed
    1. Baatz JE, Zou Y, Cox JT, Wang Z, Notter RH. High-yield purification of lung surfactant proteins SP-B and SP-C and the effects on surface activity. Protein Expr Purif 23: 180–190, 2001 - PubMed
    1. Baoukina S, Monticelli L, Risselada HJ, Marrink SJ, Tieleman DP. The molecular mechanism of lipid monolayer collapse. Proc Natl Acad Sci USA 105: 10803–10808, 2008 - PMC - PubMed
    1. Berggren P, Curstedt T, Grossmann G, Nilsson R, Robertson B. Physiological activity of pulmonary surfactant with low protein content: effect of enrichment with synthetic phospholipids. Exp Lung Res 8: 29–51, 1985 - PubMed

Publication types

MeSH terms

LinkOut - more resources